| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Vaxcyte, Inc. | Director | Common Stock | 3.04K | $88.2K | $29.00 | Jun 12, 2025 | Direct |
| Adaptimmune Therapeutics PLC | Director | Option to purchase Ordinary Shares | 660K | Jul 1, 2024 | Direct | ||
| Vaxcyte, Inc. | Director | Stock Option (right to buy) | 15.4K | Jun 12, 2025 | Direct | ||
| Vaxcyte, Inc. | Director | No securities owned. | 0 | Jul 2, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| PCVX | Vaxcyte, Inc. | Jun 12, 2025 | 2 | $0 | 4 | Jun 16, 2025 | Director |
| PCVX | Vaxcyte, Inc. | Jul 2, 2024 | 1 | $0 | 4 | Jul 3, 2024 | Director |
| PCVX | Vaxcyte, Inc. | Jul 2, 2024 | 0 | $0 | 3 | Jul 3, 2024 | Director |
| ADAP | Adaptimmune Therapeutics PLC | Jul 1, 2024 | 1 | $0 | 4 | Jul 1, 2024 | Director |
| ADAP | Adaptimmune Therapeutics PLC | Jul 3, 2023 | 1 | $0 | 4 | Jul 3, 2023 | Director |
| ADAP | Adaptimmune Therapeutics PLC | Jul 1, 2022 | 1 | $0 | 4 | Jul 1, 2022 | Director |
| ADAP | Adaptimmune Therapeutics PLC | Jul 1, 2021 | 1 | $0 | 4 | Jul 2, 2021 | Director |